More About Daisy
Daisy Wolf is an investing partner at Andreessen Horowitz, where she focuses on healthcare technology. In particular, she specializes in healthcare AI and software, consumer health, and the intersection of healthcare and fintech. Daisy is involved with companies like Honor, Marker Learning, Pomelo Care, Ribbon Health, and Season Health.
Prior to joining Andreessen Horowitz, Daisy worked at Meta in the Global Business Group, where she led company growth efforts within government and politics. In addition, Daisy has held various roles at multiple startups and covered technology at a hedge fund.
Daisy holds a JD from Yale Law School, an MBA from the Stanford Graduate School of Business, and a BA, Phi Beta Kappa from Yale College. Daisy is based in New York City and her interests include musical theater, political memoirs, and poker.
Latest Content
-
Tom Hale, CEO of ŌURA, joins Vijay Pande, founding partner, and Daisy Wolf, investment partner at CFI bio + Health.
-
Josh Clemente, cofounder and president of Levels, joins Vijay Pande, founding general partner, and Daisy Wolf, investment partner at CFI bio + Health.
-
Former gymnast and current investor Aly Raisman joins general partner Julie Yoo and investment partner Daisy Wolf of CFI bio + Health.
-
100% of stock trades used to be made by humans. Today, 80% are made by computer algorithms. AI is about to bring a similar revolution to healthcare. Over the next few decades, at least half of the $4.3 trillion dollar American healthcare industry will be AI-driven.
-
While the Google --> WebMD --> Friend protocol may be a common way to enter into the healthcare system, it is certainly not an optimal one. Most of us are not well-equipped to self-diagnose from a list of possible conditions, and our friends who work in healthcare often don’t have the exact expertise we need.
